©2026 Business Next Media Corp. All Rights Reserved. No.102, Guangfu S. Rd., Da'an Dist., Taipei City 106, Taiwan
No Labs, No Lines, Just a Phone: Neodocs Brings AI Diagnostics from India to Taiwan
In India, getting tested often means long waits, crowded clinics, and labs that are far from home. For many, especially outside major cities, even routine diagnostics are hard to access or simply avoided. That’s the gap Neodocs wants to close, using something almost everyone already has: a smartphone.
Founded in 2020 by three IIT Bombay alumni, Neodocs offers app-based medical tests that work with just a phone camera and a specialized test card. It is diagnostics without the lab, and it is already being used by more than 6,500 doctors across India.
“We’re trying to replicate what happens inside the lab machine, outside of it,” explained Anurag Meera, co-founder and Director of Neodocs. “The idea is, can we convert a smartphone into a pocket lab?”
From College Projects to Lifesaving Tools
Before Neodocs, Anurag Meera had already built two startups focused on healthcare. The first addressed maternal mortality in rural India.
“One of my friends was returning back from Shenzhen, China, and he had seen in the rural areas a lot of women die because of pregnancy-related complications because timely care is not provided to them,” noted Anurag Meera. “We designed a smartphone application where we were taking in data from multiple sensors like fetal Doppler, blood pressure, uterine activity monitoring, and then generated an algorithm to classify the risk of the pregnant women.”
That company, CareNX, is still active and operates in India and several other countries. His second venture focused on medical device development as a service. By 2019, Anurag Meera was ready to shift from services to products. He teamed up with college juniors Nikunj Malpani and Pratik Lodha, who left consulting careers to join him full time.
“In the starting, for a long period of time, it was only us three,” shared Anurag Meera. “Product development, marketing, everything, we only three of us were doing.”
During the COVID-19 lockdowns, they began testing new directions. One idea, a WhatsApp chatbot that explained blood test results, gained thousands of users. But something was missing.
“We were giving insights on the report generated by someone else,” said Anurag Meera. “Why not we generate the parameters ourselves, the reports, and give insights on that?”
Turning the Smartphone Into a Lab
That question led to Neodocs’ first product: a urine test card with 11 chemical pads that react to markers like calcium and protein. The user takes a photo using the Neodocs app, and an AI system instantly analyzes the results.
“Each chemistry has a reaction that reacts with only a particular element in the sample,” said Anurag Meera. “Based on the calcium concentration in the sample, the colors will change, and the AI can estimate what is the concentration of that particular element.”
The process takes minutes and is guided by the app, which automatically selects the best frame and adjusts for glare or shadows. “We do not want to make the user a scientist that they have to do everything perfectly,” stated Anurag Meera. “A lot of these human errors, we solve it in software.”
Neodocs also launched a blood-based test for hemoglobin using a compact optical reader. The platform is being extended to support additional tests, including HbA1c and lipid profiles, which are currently under development and awaiting regulatory approval.
“These types of products can solve for two things,” said Anurag Meera. “One is accessibility. The second is convenience.”
Neodocs’ technology has received medical device approvals from regulators in India, Indonesia, the Philippines, Sri Lanka, Nepal, and Cameroon. Its smartphone tests are used by thousands of doctors, sold on Amazon India, and deployed by pharma companies in health awareness campaigns.
“We do not require patient data to process the result,” mentioned Anurag Meera. “They just need to send the image to us. We process them, send back the results.”
Building Trust Through Doctors, Data, and Design
Instead of marketing directly to consumers, Neodocs has focused on trust-building through physicians and public health systems. Pharmaceutical firms like AstraZeneca, Bayer, and Cipla use the tests in clinical outreach programs. In India, more than 6,500 doctors now use Neodocs regularly.
“Doctors trust it, and that builds trust with patients,” said Anurag Meera.
The company is also expanding across Southeast Asia and parts of Africa, where healthcare access gaps resemble those in India. Taiwan has become a key base for development, manufacturing, and clinical trial discussions. Neodocs has participated in both the Garage+ Global Startup Program and TMU Biomed Accelerator.
“Regulatory approvals or clinical trials from Taiwan are very well reputed,” added Anurag Meera. “It is a mark of credibility.”
For now, Neodocs provides test results only. “We just have the report. We do not know what medication the person is on,” said Anurag Meera. “And we are not allowed to make clinical recommendations.”
Still, the potential to layer in non-medical suggestions like diet and wellness advice remains open for the future. So does the broader goal: making diagnostics simple, scalable, and available to anyone, anywhere.
“Healthcare is something I like,” said Anurag Meera, smiling. “If we can work with the ecosystem, then we can work on such products as well in future.”
©2026 Business Next Media Corp. All Rights Reserved. No.102, Guangfu S. Rd., Da'an Dist., Taipei City 106, Taiwan